About Artios
|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
The Glenn Berge Building, Babraham Research Campus, Cambridge, GB
|
|
Artios is a leading independent DNA Damage Response (DDR) company focussed on developing first-in-class treatments for cancer. Established in May 2016, the Company is led by an experienced scientific and leadership team with proven expertise in DDR drug discovery. Artios is building a pipeline of next-generation DDR programmes, including through a unique partnership with Cancer Research Technology (CRT), the development and commercialisation arm of Cancer Research UK (CRUK), and with leading DNA repair researchers worldwide. The Company’s investors include SV Life Sciences, Merck Ventures, Imperial Innovations, Arix Bioscience PLC, CRT Pioneer Fund (managed by Sixth Element Capital), and AbbVie Ventures. Artios is based at the Babraham Institute in Cambridge, UK.
|
Artios Email Format
The widely used Artios email format is {first}.{last}@artiospharma.com (e.g. [email protected]), which is used 100% of the time.
| Artios Email Formats | Example Email Formats | Percentage |
|---|---|---|
| {first}.{last} | [email protected] |
100%
|
Artios Alternatives
Frequently Asked Questions about Artios
What is Artios email format?
The widely used Artios email format is {first}.{last} (e.g. [email protected]) with 100% adoption across the company.
What is Artios customer service number?
To contact Artios customer service number call here 01223 867900. To contact Artios customer service number in your country click here to find.
Who is the CEO of Artios?
Niall Martin is the CEO of Artios. To contact Niall Martin email at [email protected] or [email protected].
Artios Staff Directory
Search Artios Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Search Portal
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
